Clinical Trials Browser

Completed × Simvastatin × Gastrointestinal × Clear all

Carcinoma, Renal Cell, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Sarcoma, Clear Cell, Rhabdoid Tumor

NCT02026583 2018-01-17

A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients

Phase 2 Completed

43 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00944463 2017-02-17

Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients

Phase 2 Completed

106 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01099085 2017-02-17

Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients

Phase 3 Completed

207 enrolled

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

NCT00313859 2012-02-02

Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC

Phase 2 Completed

50 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Clinical Trials

AflacST1402

A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients

Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients

Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients

Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC